CPDC
  • Home
  • Products
    • Glucovision® (FDG)
    • Investigational Probes
  • Services
    • Contract Research
    • GMP Contract Manufacturing
    • Microbiological Testing
    • Quality Control and Quality Assurance
    • Regulatory Affairs
  • R & D
    • Investigator Sponsored Research Program (ISRP)
      • General ISRP Guidelines
      • Submitting an ISRP Proposal
      • ISRP Project Selection Criteria
      • ISRP Intellecutal Property Policy
    • Non-reactor Based Isotope Supply Contribution Program (NISP)
  • News
  • Events
  • Careers
  • About CPDC
    • Milestones
    • Leadership Team
    • Our Partners
    • What are Molecular Imaging Probes?
    • Reports
    • CPDC Video
  • Contact Us
    • Directions
11th October 2011
CPDC / Reports

Reports

 

 
 

The Impact Report 2010-2011

 
 

 

2009-10 CPDC Annual Report

 

 
 

 

2008-09 CPDC Annual Report – English

2008-09 CPDC Annual Report – French

 

 

About CPDC

  • Milestones
  • Leadership Team
  • Our Partners
  • What are Molecular Imaging Probes?
  • Reports
  • CPDC Video

Did you know?

  • CPDC is one of Ontario’s largest manufacturers of Fludeoxyglucose – the world’s most widely used PET imaging probe.

    Learn More

  • Molecular PET imaging probes are used primarily to diagnose cancer, heart disease and neurological conditions.

    Learn More

  • The half-life of the fluorine-18 isotope, used to make many PET probes, is only 109.8 minutes. In about a day, the isotopes injected into a patient have either been excreted or have completed their decay.

  • In the last three years, CPDC has introduced three new molecular probes to Ontario for clinical trials in disease diagnosis and drug development.

    Learn More

  • CPDC’s Investigator Sponsored Research Program helps researchers move discoveries in molecular probe technology from the lab to the clinic.

    Learn More

  • CPDC, along with a national team of experts, is working to develop alternative, non-reactor based sources of medical isotopes to ensure adequate supplies for Canadians.

    Learn More

  • CPDC is developing several “orphan probes” to help our health care system diagnose and treat thousands of patients in Canada suffering from certain rare diseases.

  • CanProbe is a new joint-venture company formed by CPDC and University Health Network to meet increasing Canadian and global demand for molecular probes.

    Learn More

  • Molecular probes can show a tumour’s biochemical response to treatment in just a few days, unlike conventional modes like MRI or CT, which may not show a change in tumour size for several weeks.

    Learn More

  • Global drug companies are using CPDC’s know-how and world-class facilities to develop and test new drugs and molecular probes.

    Learn More

  • During the recent shortage of medical isotopes, CPDC provided substitutes for use in bone scans and imaging kidney function.

    Learn More

  • • Over 200 professionals in medical imaging attend CPDC’s Annual Probe Development Workshop to learn about the latest advances in research and application of molecular probes.

    Learn More

Careers

Join a dynamic, growing team that is passionate about making a difference and improving the lives of patients in Canada and around the world. Explore the opportunities at CPDC

View Opportunities

Sign up for CPDC Updates

  • Our Partners









  • Annual Probe Workshop

    Save the date for our

    4th Annual Probe Development Workshop

    Monday, June 25, 2012
    Learn More

  • Latest News

    • Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clinical Trials
    • Joint Venture Announced to Expand Use of Molecular Imaging in Ontario for Patient Care and Research of Cancer and Other Serious Diseases
    • CPDC Joins National Project to Develop Alternative Sources of Medical Isotopes

  • Contact Us

    Centre for Probe Development and
    Commercialization

    McMaster University
    Nuclear Research Building
    1280 Main Street West
    Hamilton, Ontario, Canada, L8S 4K1
    cpdc@imagingprobes.ca
    (905) 525-9140 ext. 21212

Copyright © 2011 CPDC All rights reserved. Web Design by GraphixFlo.com